Search Results: research/ (27)

Rose Law Group PC
University of Massachusetts-Amherst Professor Lyle Craker has been trying for almost 11 years to get federal permission to grow marijuana for medical research

On Friday, May 11, the U.S. Court of Appeals for the First Circuit in Boston will hear oral arguments in a federal lawsuit against the Drug Enforcement Administration for denying University of Massachusetts-Amherst Professor Lyle Craker a license to grow marijuana for privately funded medical research.

The arguments culminate nearly 11 years of legal and administrative proceedings trying to end the National Institute on Drug Abuse (NIDA) monopoly on the marijuana supply for research.
The lawsuit is in response to an August 15, 2011 final order issued by the DEA rejecting its own DEA Administrative Law Judge’s 2007 recommendation that it would be “in the public interest” to grant Prof. Craker the research license. A laboratory at the University of Mississippi, funded by NIDA, is currently the one and only facility in the United States allowed to grow marijuana for research.

Worth Repeating
By Ron Marczyk, R.N.
Health Education Teacher (Retired)

A new understanding of the neurobiology of cannabis is emerging, namely the “endocannabinoid induced aerobic bliss state,” or simply the endocannabinoid runners’ high.

For users of medical marijuana, a new use for this miracle plant is at hand: its ability to produce “the psychology of exercise motivation.”
“Recent findings show that exercise increases serum concentrations of endocannabinoids, a result suggestive of a new possible explanation for a number of these changes. The cannabinoids produce psychological states that closely parallel several experiences described as being related to the runner’s high. Compared with the opioid analgesics, the analgesia produced by the endocannabinoid system is more consistent with exercise induced analgesia. Activation of the endocannabinoid system also produces sedation, anxiolysis, a sense of wellbeing, reduced attentional capacity, impaired working memory ability, and difficulty in time estimation. This behavioural profile is similar to the psychological experiences reported by long distance runners.” ~ From Endocannabinoids and Exercise / Br J Sports Med. 2004 October

Patients Against I-502

​Washington state’s marijuana legalization Initiative 502 has plenty of prominent backers and a healthy war chest of money heading towards the November election. So why do many of the state’s most prominent cannabis advocates oppose it?
One of the most troublesome reasons, according to Patients Against I-502, is its faulty DUI provision which would create a per se DUI charge for anyone testing over the low, arbitrary and scientifically unsupported blood THC level of of five nanograms per milliliter (5 ng/ml).

Welcome to Room 420, where your instructor is Mr. Ron Marczyk and your subjects are wellness, disease prevention, self actualization, and chillin’.
Worth Repeating
​By Ron Marczyk, R.N.
Health Education Teacher (Retired)
Lumír Ondřej Hanuš (left), discoverer of endogenous ligand, anandamide, from brain (1992) and Raphael Mechoulam (right), discoverer of psychoactive compound, (-)-trans-delta-9-tetrahydrocannabinol, from Cannabis sativa L. (1964). Both compounds bind to the CB1 and 2 cannabinoid receptors in the brain.
This post is dedicated to these two great medical researchers. The fathers of homeostatic cannabinoid based medicine:
Lumír Ondřej Hanuš, discoverer of the endogenous ligand, anandamide, from the brain (1992) and Raphael Mechoulam, discoverer of the psychoactive compound, THC, from Cannabis sativa (1964). Both compounds bind to the CB1 and 2 cannabinoid receptors in the brain.
These two men need to be nominated and awarded the 2012  Nobel Prize in medicine for discovering the healing potential of cannabis. Their discoveries will save the human race a great deal of suffering. Thank you for your gift to humanity, gentlemen.
Nobel ballots open this summer!
The inevitable crackdown came, not as a result of harmless cannabis nor even of is frisky big brother, LSD — but due to the same, tired old death drugs that have been killing people and destroying lives for generations

Drug Screen of Surfers Could Wipe Out Sport’s Rebellious Image

The mystique of surfing, since its music-fueled rise on the American West Coast during the 1960s, has always had a lot to do with rebellion, with alternatives, with a countercultural image. With the “bushy bushy blonde hair” and the rest of the accoutrements, of course, came marijuana and LSD, drugs of choice for the surfing culture which, unlike traditional narcotics and stimulants, didn’t noticeably reduce the physical abilities of those participating in the sport.
The mystic search to catch the perfect wave became the obsession of many a stoner — but the perfection of the art of surfing was a double-edged sword. It brought with it the inevitable commercialization of the sport, and big-purse surf competitions, along with their attendant product endorsements, became the tail that started wagging the dog. 

Injustice In Seattle
White House Drug Czar Gil Kerlikowske is lying his ass off.

​The Obama Administration has officially “responded” to the “We The People” online petitions regarding marijuana legalization. Well, kind of — if you’re willing to dignify a bureaucrat mouthing the same old meaningless platitudes by calling that a “response.”

Drug Czar Gil Kerlikowske chose to respond to eight petitions regarding cannabis law reform with one blanket response. Speaking of which, ol’ Gil tried to put a wet blanket on the grass-fire that is the legalization movement, but it turns out all he could do is blow smoke.
Conventional wisdom dictates that when you have to make a press release, but really want it to get as little media attention as possible, you release it late on a Friday — which is exactly what the White House has done with this one. That way, all the top-line reporters have gone home or are bar-hopping by the time the release hits, and it has Saturday and Sunday to blow over before the week’s regular news cycle resumes Monday morning.
Kerlikowske, required by law as director of the ONDCP to oppose marijuana legalization, is either completely unaware that history has passed him by, or is pointedly ignoring the obvious. His refusal to even meaningfully engage with drug policy reform advocates shows that worse than being useless, he is an intentional obstruction — a willing part of the problem.

Addiction Inbox

​The sad tradition of inaccurate, sensationalistic cannabis reporting continues in the United Kingdom’s tabloid press. Deeply clueless reporter Tamara Cohen at the Daily Mail plumbed new depths of silliness on Tuesday with the breathless headline: One cannabis joint ‘can bring on schizophrenia’ as well as damaging memory.

Never mind that, even as cannabis usage rates have skyrocketed, the ratio of schizophrenics in the population has remained constant at one or two percent for the past 60 years. Never mind that no human beings were involved in the tests, and never mind that no marijuana was used, either.

Photo: Alaska Hemp
“Hey, I think I smell something…”

​A press release from the Alaska State Troopers proudly unveiled the results of a three-year(!) study which, not shockingly, determined that the odor of marijuana may be associated with the presence of marijuana.

Now, stop it. Maybe Alaska State Troopers (AST) don’t have much to do; I’m sure their lives could use a little more excitement. And they have all those “federally forfeited illegal drug proceeds” to spend on, well, something.
The troopers used the University of Alaska Anchorage (UAA) Justice Center to analyze three years’ worth of marijuana grows which they busted. The study analyzed 200 marijuana grow searches conducted by Alaska State Troopers covering 2006 to 2008.

Photo: Jesse Pearson
Dude! I knew it!

​Connecticut state Senator Toni Boucher doesn’t like medical marijuana, and she seems proud of herself for trying to stop it in her state, according to a press release her office sent out on Thursday.

According to the breathless (and almost entirely brainless) release, Sen. Boucher “valiantly tried to stop a medical marijuana bill from getting out of the Finance Revenue and Bonding Committee.” See there? Trying to stop seriously ill patients from getting the only medicine that helps is “valiant” now, get it?

Photo: LIFE
Drug Czar Gil Kerlikowske said this week that there are “over 100”  ongoing FDA studies on marijuana. There are two.

​U.S. Drug Czar Gil Kerlikowske sat down for an interview with The Daily Caller’s Mike Riggs earlier this week — and managed to tell one hell of a whopper while he was at it.

When Riggs asked the Drug Czar, “You’ve said before that you don’t see medical benefits to smoked marijuana and also that the jury is still out on medical marijuana. What sort of scientific consensus does the ONDCP [Office of National Drug Control Policy] require? How many studies have to come out arguing for medical benefits? What do you need to see?”
“You know there are over 100 groups doing marijuana research,” the Czar replied, “and they’re getting their marijuana from the University of Mississippi. There are several things in clinical trials right now. So we’ll just have to wait for those.”